Providence Therapeutics Investors
Providence Therapeutics is a biotechnology company that develops a personalized mRNA cancer vaccine designed to treat ovarian cancer.
Industry:
P4 Medicine
Investor Type:
Healthcare Company
Founded Date:
2015
Headquarters:
Toronto, Ontario, Canada